November 15, 2018 – Patrick Duncker, PhD Defense
http://immunology.medicine.umich.edu/people/patrick-duncker
October 31, 2018 – Ashley Munie, Immunology Research Seminar
http://immunology.medicine.umich.edu/immunology-journal-club
October 19, 2018 – Dr. Andrew Sas, Neurology Research Seminar
August 22, 2018 – Dr. Benjamin Segal, 3rd Annual Payer & Provider Workshops in Multiple Sclerosis
August 17, 2018 – Jesse Washnock-Schmid’s Going Away Party
August 2, 2018 – ECTRIMS Travel Award Given to Segal Lab Member
PhD Student Patrick Duncker received a travel award from the European Committee for Research and Treatment of Multiple Sclerosis (ECTRIMS) to support his travel to present at the ECTRIMS Congress in Berlin, Germany in October of this year.
July 17, 2018 - New Paper Highlights Pathway to CNS Lesion Localization
The Segal Lab has published a new (July 16, 2018) paper in the Journal of Neuroinflammation detailing evidence of a previously undiscovered mechanism in which cytokines IFNγ and CXCL2 interact to regulate central nervous system lesion location in an experimental allergic encephalomyelitis (EAE) mouse model. You can read the full abstract via PubMed at this link.
July 7-13, 2018 FASEB Translational Neuroimmunology
Dr. Andrew Sas, Patrick Duncker and Dr. Jeff Atkinson presenting at FASEB.
June 1, 2018 Andrew Sas gives talk at the 15th Annual Neurobiology of Disease Symposium at the University of Michigan
June 7, 2018 – 17th Annual Immunology Retreat
April 16, 2018 Dr. Segal explains the huge advances in MS Treatment
It was surprising for many of us when a well-known actress recently revealed she’s been dealing with multiple sclerosis (MS) for 15 years. Jamie Lynn Sigler said in interviews she was symptom-free for a long time, and now takes medication to keep her symptoms stable.Dr. Benjamin Segal, Holtom-Garrett Professor of Neurology and director of the U-M Multiple Sclerosis Center, explains that MS treatment has grown by leaps and bounds in the past 20 years.“I myself have many patients who are high-functioning, successful contributors to society, from CEOs and professors to doctors and lawyers. Many of these individuals have no signs of MS that are apparent to co-workers or acquaintance,” Segal wrote.
Read the full blog: http://uofmhealthblogs.org/neurohealth/a-revolution-in-ms-treatment/27090/
May 30, 2018 – Neurobiology of Disease Symposium
February 4, 2018 - Patrick Duncker awarded second place for best oral presentation at ACTRIMS 2018 (from over 220 abstracts submitted)
February 1, 2018- Patrick Duncker, Andrew Sas, and Nikki Wilkinson present posters at the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) meeting